Scapa Group (SCPA)

Sector:

Industrial Chemicals

Index:

FTSE AIM 50

 245.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 403.00
  • 52 Week Low: 157.00
  • Currency: UK Pounds
  • Shares Issued: 155.24m
  • Volume: 10,000
  • Market Cap: £381.12m
  • RiskGrade: 254
  • Beta: 0.94

Scapa profits take a hit from loss of ConvaTec contract

By Iain Gilbert

Date: Wednesday 09 Oct 2019

LONDON (ShareCast) - (Sharecast News) - Tapes and adhesives manufacturer Scapa expects interim profits to be impacted by the loss of its contract with ConvaTec but said revenues still looked set to grow on the back of a strong performance in its healthcare unit.
Scapa said on Wednesday that trading in the six months ended 30 September had been in line with expectations, with revenues up 14.3% year-on-year, or 10.4% on a constant currency basis.

The AIM-listed group's healthcare unit reported a 23% increase in revenues despite the loss of ConvaTec volumes. However, Scapa expected its profits to be around 17% lower year-on-year as a result of the lost contract with the FTSE 250 medical products firm.

Scapa anticipated that the second half would see it benefit from a strong pipeline of new products and technology transfers from both new and existing customers.

The group's industrial unit saw revenues increase by 3.9% despite strong market headwinds.

While Scapa expects market-wide challenges to continue, the firm considers itself to "well-positioned" to make further progress against its strategic, operational and financial objectives and remains confident in its outlook.

As of 1115 BST, Scapa shares were down 0.74% at 215p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Scapa Group Market Data

Currency UK Pounds
Share Price 245.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 403.00
52 Week Low 157.00
Volume 10,000
Shares Issued 155.24m
Market Cap £381.12m
Beta 0.94
RiskGrade 254

Scapa Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80.65% below the market average80.65% below the market average80.65% below the market average80.65% below the market average80.65% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Price Trend
19.9% below the market average19.9% below the market average19.9% below the market average19.9% below the market average19.9% below the market average
5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average
Income
83.63% below the market average83.63% below the market average83.63% below the market average83.63% below the market average83.63% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
23.28% below the market average23.28% below the market average23.28% below the market average23.28% below the market average23.28% below the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 5
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Scapa Group Dividends

  Latest Previous
  Final Final
Ex-Div 25-Jul-19 19-Jul-18
Paid 23-Aug-19 17-Aug-18
Amount 2.90p 2.40p

Trades for 09-Dec-2019

Time Volume / Share Price
08:14 10,000 @ 242.00p

Scapa Group Key Personnel

CEO Heejae Chae
CFO Oskar Zahn

Top of Page